According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to reach USD 749.05 Million in 2023, Sales grew at a CAGR of 5.2% from 2018 to 2023. Patients with myelofibrosis can be …
Category Archives: Healthcare Trends
Global Helicobacter Pylori Infections Treatment Market Poised to Reach USD 1,260 Million by 2033 expand at a 7.04% value CAGR | FMI
The global helicobacter pylori infections treatment market is on a robust growth trajectory, with its value projected to escalate from USD 638.3 million in 2023 to an impressive USD 1,260 million by 2033. This expansion, driven by a steady Compound Annual Growth Rate (CAGR) of 7.04%, reflects the growing urgency to address the widespread prevalence …
Global Patient Monitoring Devices Market Set to Soar to USD 125.2 Million by 2032 with a CAGR of 10.5% | Reports FMI
Future Market Insights (FMI) has revealed an insightful new report showcasing the remarkable growth trajectory of the global patient monitoring devices market. Valued at USD 46.4 million in 2022, the market is poised to achieve unprecedented expansion, with projections indicating a staggering valuation of USD 125.2 million by 2032. This equates to a robust Compound …
Global Joint Replacement Market Set to Reach USD 32.2 Billion by 2035 Amid Rising Demand from Aging Population and Degenerative Joint Disorders | FMI
The global joint replacement market is poised for steady growth, with revenue expected to increase from USD 20.3 billion in 2025 to USD 32.2 billion by 2035, rising at a CAGR of 4.7% over the forecast period. This follows an already robust performance in 2024, when global sales were valued at USD 19.4 billion. The …
Rising Demand for Neurological Treatments Fuels Growth in the Multiple System Atrophy Therapeutics Market Projected to Reach USD 211.1 Million by 2033 at a 4.4% CAGR | FMI
The global multiple system atrophy therapeutics market is witnessing steady growth, underpinned by technological advancements, rising awareness of neurodegenerative conditions, and increased healthcare investment. According to a recent market analysis, the market was valued at USD 137.3 million in 2023 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.4%, reaching …
Global Alpha-1 Antitrypsin Deficiency Market to Reach USD 10 Billion by 2033 Amid Surge in R&D Investments and Rising Prevalence of Target Illnesses | FMI
According to recent projections by Future Market Insights (FMI), the global alpha-1 antitrypsin deficiency market is poised for significant growth, reaching an estimated USD 10 Billion by 2033, up from USD 3 Billion in 2023. This represents a compound annual growth rate (CAGR) of 12.8% during the forecast period from 2023 to 2033. Alpha-1 Antitrypsin …
Global Spine Pain Market is set to reach USD 13.08 Million by 2034 at a 5% CAGR | FMI
The spine pain industry is predicted to be valued at USD 8.03 billion by 2024. The lower back pain market size is estimated to be USD 13.08 billion by 2034, projected at a CAGR of 5%. The surge in the prevalence of spine-related conditions, fueled by aging populations, sedentary lifestyles, and obesity, acts as a …
Global Chronic Wound Care Market to Reach USD 27 Billion by 2035 expanding at 3.8% CAGR, Amidst Technological Advancements | Future Market Insights, Inc.
The global chronic wound care market is projected to experience steady growth, reaching USD 27,076.5 million by 2035, expanding at a CAGR of 3.8%. In 2024, the market revenue stood at USD 17,941.7 million, with forecasts indicating an increase to USD 18,675.3 million by 2025. Innovations Driving Market Expansion The wound care industry is witnessing …
Global Non-Small Cell Lung Carcinoma (NSCLC) Market Set for Robust Growth, Projected to Reach USD 21.40 Billion by 2033
The global non-small cell lung carcinoma market is poised for significant expansion over the next decade, according to new industry projections. Valued at USD 8.25 billion in 2023, the NSCLC market is expected to surge to an impressive USD 21.40 billion by 2033, registering a strong compound annual growth rate (CAGR) of 10% during the …
Global Primary Sclerosing Cholangitis (PSC) Market Set to Soar to USD 314.26 Million by 2033 | FMI
The global primary sclerosing cholangitis (PSC) market is on an impressive growth trajectory, with forecasts estimating a market valuation of USD 314.26 million by 2033. This robust expansion is driven by a significant compound annual growth rate (CAGR) of 7.6% from 2023 to 2033, reflecting a growing commitment to addressing liver diseases and the impact …